The Puerto Rico Clinical and Translational Research Consortium (PRCTRC) was established on September 2010 with the idea of implementing productive collaborations among local institutions and have a broader impact across all levels of research in health disparities in Puerto Rico. We are a centralized clinical and translational research program focused on health problems prevalent in our community.
The PRCTRC leverages the intellectual and physical resources of three major medical and health science centers on the island: The University of Puerto Rico Medical Sciences Campus (UPR-MSC), the Universidad Central del Caribe (UCC), and the Ponce Health Sciences University (PHSU) to address and reduce health disparities that most impact Hispanic populations.
Through its inclusive and integrated structure, the PRCTRC has fostered a synergistic environment that supports research across the clinical and translational research continuum in our four primary clinical focus areas: HIV/AIDS, neuroscience, cardiovascular and metabolic disease, and cancer. These four disease states represent some of the greatest threats to the health of our population.
To serve as a vital and catalytic element in the efforts to understand, define, and address health disparities in Hispanic populations.
To create, develop and support an integrated, island-wide program dedicated to the conduct of clinical and translational research for reducing health disparities in Hispanic populations.
- Facilitate the generation and translation of knowledge from the bench into the community by establishing a centralized program focused on reducing health disparities among Hispanic populations.
- Enhance and support existing training and mentoring programs to increase the number of new minority investigators in clinical and translational research.
- Encourage collaborations among basic, clinical, and social scientists and community networks and health programs.
- Enhance and integrate existing infrastructure for clinical and translational research across Puerto Rico to support and expand clinical and translational research in health disparities.